Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE3.6300
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.5000/ 6
- Ask / Lots3.6500/ 4
- Open / Previous Close3.5100 / 3.6300
- Day Range
- 52 Week Range
- Volume1,098,149
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 42460 | 3.505 |
| 09:34 ET | 9924 | 3.5323 |
| 09:36 ET | 20935 | 3.51 |
| 09:38 ET | 13566 | 3.515 |
| 09:39 ET | 16860 | 3.56 |
| 09:41 ET | 1689 | 3.56 |
| 09:43 ET | 1490 | 3.56 |
| 09:45 ET | 3787 | 3.55 |
| 09:48 ET | 3759 | 3.5401 |
| 09:50 ET | 500 | 3.55 |
| 09:52 ET | 700 | 3.55 |
| 09:54 ET | 9448 | 3.56 |
| 09:56 ET | 300 | 3.58 |
| 09:57 ET | 800 | 3.555 |
| 09:59 ET | 2300 | 3.55 |
| 10:01 ET | 28187 | 3.555 |
| 10:03 ET | 11559 | 3.535 |
| 10:06 ET | 3159 | 3.525 |
| 10:08 ET | 13929 | 3.5098 |
| 10:10 ET | 3210 | 3.535 |
| 10:12 ET | 7230 | 3.525 |
| 10:14 ET | 3847 | 3.5499 |
| 10:15 ET | 1730 | 3.525 |
| 10:17 ET | 3997 | 3.525 |
| 10:19 ET | 2113 | 3.5393 |
| 10:21 ET | 100 | 3.535 |
| 10:24 ET | 11490 | 3.51 |
| 10:26 ET | 9682 | 3.525 |
| 10:28 ET | 2640 | 3.525 |
| 10:30 ET | 200 | 3.535 |
| 10:32 ET | 100 | 3.5394 |
| 10:35 ET | 6405 | 3.505 |
| 10:37 ET | 7830 | 3.52 |
| 10:39 ET | 30820 | 3.505 |
| 10:42 ET | 54697 | 3.515 |
| 10:44 ET | 6410 | 3.53 |
| 10:46 ET | 5670 | 3.555 |
| 10:48 ET | 2260 | 3.54 |
| 10:50 ET | 1000 | 3.525 |
| 10:51 ET | 200 | 3.535 |
| 10:53 ET | 1300 | 3.535 |
| 10:55 ET | 1320 | 3.535 |
| 10:57 ET | 3155 | 3.545 |
| 11:00 ET | 810 | 3.545 |
| 11:02 ET | 10700 | 3.541 |
| 11:04 ET | 3364 | 3.545 |
| 11:06 ET | 4727 | 3.535 |
| 11:08 ET | 3238 | 3.545 |
| 11:09 ET | 1400 | 3.545 |
| 11:11 ET | 400 | 3.545 |
| 11:13 ET | 3222 | 3.555 |
| 11:15 ET | 600 | 3.555 |
| 11:18 ET | 1267 | 3.565 |
| 11:20 ET | 400 | 3.565 |
| 11:22 ET | 1142 | 3.565 |
| 11:24 ET | 1600 | 3.57 |
| 11:26 ET | 2900 | 3.58 |
| 11:27 ET | 800 | 3.585 |
| 11:29 ET | 16477 | 3.59 |
| 11:31 ET | 3027 | 3.57 |
| 11:33 ET | 4770 | 3.575 |
| 11:36 ET | 500 | 3.575 |
| 11:38 ET | 3600 | 3.57 |
| 11:40 ET | 300 | 3.575 |
| 11:42 ET | 300 | 3.57 |
| 11:44 ET | 910 | 3.575 |
| 11:45 ET | 2696 | 3.57 |
| 11:47 ET | 4938 | 3.58 |
| 11:49 ET | 100 | 3.575 |
| 11:51 ET | 200 | 3.575 |
| 11:54 ET | 3165 | 3.585 |
| 11:56 ET | 620 | 3.58 |
| 11:58 ET | 110 | 3.575 |
| 12:00 ET | 100 | 3.575 |
| 12:02 ET | 1261 | 3.575 |
| 12:03 ET | 1163 | 3.575 |
| 12:05 ET | 14443 | 3.5511 |
| 12:07 ET | 100 | 3.555 |
| 12:09 ET | 679 | 3.559 |
| 12:12 ET | 300 | 3.555 |
| 12:14 ET | 1700 | 3.555 |
| 12:16 ET | 4653 | 3.555 |
| 12:18 ET | 4956 | 3.565 |
| 12:20 ET | 5673 | 3.565 |
| 12:21 ET | 2772 | 3.56 |
| 12:23 ET | 238 | 3.565 |
| 12:25 ET | 300 | 3.565 |
| 12:27 ET | 1000 | 3.565 |
| 12:30 ET | 1067 | 3.565 |
| 12:32 ET | 800 | 3.565 |
| 12:34 ET | 400 | 3.565 |
| 12:36 ET | 3804 | 3.57 |
| 12:38 ET | 16570 | 3.555 |
| 12:39 ET | 650 | 3.56 |
| 12:41 ET | 1500 | 3.565 |
| 12:43 ET | 900 | 3.565 |
| 12:45 ET | 10600 | 3.56 |
| 12:48 ET | 16062 | 3.555 |
| 12:50 ET | 1320 | 3.56 |
| 12:52 ET | 400 | 3.57 |
| 12:54 ET | 100 | 3.57 |
| 12:56 ET | 400 | 3.565 |
| 12:57 ET | 2771 | 3.555 |
| 12:59 ET | 1604 | 3.555 |
| 01:01 ET | 100 | 3.56 |
| 01:03 ET | 6204 | 3.555 |
| 01:06 ET | 6600 | 3.56 |
| 01:08 ET | 500 | 3.555 |
| 01:10 ET | 600 | 3.555 |
| 01:12 ET | 5128 | 3.555 |
| 01:14 ET | 1435 | 3.555 |
| 01:15 ET | 1750 | 3.555 |
| 01:17 ET | 5461 | 3.565 |
| 01:19 ET | 200 | 3.565 |
| 01:21 ET | 2960 | 3.5699 |
| 01:26 ET | 2186 | 3.565 |
| 01:28 ET | 5988 | 3.5894 |
| 01:30 ET | 5325 | 3.585 |
| 01:32 ET | 100 | 3.585 |
| 01:33 ET | 1400 | 3.585 |
| 01:35 ET | 10709 | 3.575 |
| 01:37 ET | 7626 | 3.57 |
| 01:39 ET | 1567 | 3.56 |
| 01:42 ET | 3128 | 3.565 |
| 01:44 ET | 702 | 3.56 |
| 01:46 ET | 2408 | 3.555 |
| 01:48 ET | 1221 | 3.55 |
| 01:50 ET | 104 | 3.555 |
| 01:51 ET | 12063 | 3.53 |
| 01:53 ET | 606 | 3.535 |
| 01:55 ET | 1624 | 3.535 |
| 01:57 ET | 2423 | 3.54 |
| 02:00 ET | 1204 | 3.535 |
| 02:02 ET | 1000 | 3.54 |
| 02:04 ET | 328 | 3.5345 |
| 02:06 ET | 5046 | 3.53 |
| 02:08 ET | 2600 | 3.515 |
| 02:09 ET | 6116 | 3.53 |
| 02:11 ET | 1095 | 3.53 |
| 02:13 ET | 2000 | 3.53 |
| 02:15 ET | 656 | 3.5392 |
| 02:18 ET | 938 | 3.535 |
| 02:20 ET | 2403 | 3.54 |
| 02:22 ET | 1000 | 3.535 |
| 02:24 ET | 100 | 3.54 |
| 02:26 ET | 300 | 3.535 |
| 02:27 ET | 5981 | 3.52 |
| 02:29 ET | 2960 | 3.535 |
| 02:33 ET | 444 | 3.535 |
| 02:36 ET | 1127 | 3.535 |
| 02:38 ET | 4873 | 3.52 |
| 02:40 ET | 602 | 3.52 |
| 02:42 ET | 737 | 3.521 |
| 02:44 ET | 604 | 3.52 |
| 02:47 ET | 400 | 3.525 |
| 02:49 ET | 100 | 3.525 |
| 02:51 ET | 1046 | 3.525 |
| 02:54 ET | 369 | 3.521 |
| 02:56 ET | 2850 | 3.53 |
| 02:58 ET | 100 | 3.535 |
| 03:00 ET | 388 | 3.535 |
| 03:02 ET | 300 | 3.54 |
| 03:03 ET | 900 | 3.535 |
| 03:05 ET | 1161 | 3.5308 |
| 03:07 ET | 2316 | 3.545 |
| 03:09 ET | 12077 | 3.525 |
| 03:12 ET | 8582 | 3.525 |
| 03:14 ET | 1300 | 3.525 |
| 03:16 ET | 2616 | 3.535 |
| 03:18 ET | 700 | 3.535 |
| 03:20 ET | 20517 | 3.55 |
| 03:21 ET | 2108 | 3.545 |
| 03:23 ET | 10718 | 3.55 |
| 03:25 ET | 3800 | 3.55 |
| 03:27 ET | 11816 | 3.541 |
| 03:30 ET | 2200 | 3.54 |
| 03:32 ET | 4208 | 3.545 |
| 03:34 ET | 9789 | 3.555 |
| 03:36 ET | 2411 | 3.56 |
| 03:38 ET | 1200 | 3.56 |
| 03:39 ET | 1200 | 3.5505 |
| 03:41 ET | 19468 | 3.59 |
| 03:43 ET | 2100 | 3.59 |
| 03:45 ET | 3691 | 3.59 |
| 03:48 ET | 21053 | 3.605 |
| 03:50 ET | 1200 | 3.605 |
| 03:52 ET | 13578 | 3.625 |
| 03:54 ET | 28547 | 3.64 |
| 03:56 ET | 23384 | 3.64 |
| 03:57 ET | 41783 | 3.635 |
| 03:59 ET | 51527 | 3.63 |
Jun 20, 2024
DJ Mereo BioPharma Group Is Maintained at Outperform by Leerink Partners, from 8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
8:19AM ET on Thursday Jun 20, 2024 by Dow Jones
Jun 14, 2024
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 7:50AM ET on Friday Jun 14, 2024 by Dow Jones
7:50AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 13, 2024
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 550.1M | -11.6x | --- |
Stoke Therapeutics Inc | 704.1M | -5.7x | --- |
Immunome Inc | 725.6M | -2.2x | --- |
AnaptysBio Inc | 684.6M | -4.0x | --- |
SS Innovations International Inc | 725.6M | -31.0x | --- |
Praxis Precision Medicines Inc | 707.6M | -2.6x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $550.1M |
|---|---|
Revenue (TTM) | $10.0M |
Shares Outstanding | 152.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-0.31 |
Book Value | $0.44 |
P/E Ratio | -11.6x |
Price/Sales (TTM) | 55.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -416.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
